4.6 Review

CXCL5: A coachman to drive cancer progression

Journal

FRONTIERS IN ONCOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2022.944494

Keywords

CXCL5; chemokine; immunosuppressive microenvironment; tumor angiogenesis; tumor migration

Categories

Funding

  1. National Natural Science Foundation of China
  2. Beijing xisike clinical oncology research foundation
  3. [81301898]
  4. [sy2018-249]

Ask authors/readers for more resources

CXCL5, a chemokine, plays a critical role in human malignant tumors, potentially associated with tumor metastasis and angiogenesis. Regulating CXCL5 may be a promising approach for tumor therapy.
Chemokines are a class of pro-inflammatory cytokines that can recruit and activate chemotactic cells. C-X-C motif chemokine ligand 5 (CXCL5) is a member of the chemokine family binding CXCR2 (C-X-C Motif Chemokine Receptor 2), a G-protein coupled receptor. Accumulated evidence has shown that dysregulated CXCL5 participates in tumor metastasis and angiogenesis in human malignant tumors. In this review, we summarized the advances in research on CXCL5, including its dysregulation in different tumors and the mechanism associated with tumor behavior (formation of the immunosuppressive microenvironment, promotion of tumor angiogenesis, and metastasis). We also summarized and discussed the perspective about the potential application of CXCL5 in tumor therapy targeting the tumor inflammatory microenvironment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available